Literature DB >> 33380298

TGF-β1-based CRISPR/Cas9 Gene Therapy Attenuates Radiation-induced Lung Injury.

Shuai Zhen1, Rong Qiang2, Jiaojiao Lu1, Xiaoqian Tuo1, Xiling Yang1, Xu Li1.   

Abstract

BACKGROUND: Radiation-induced lung injury (RILI) is lacking effective therapeutic strategies. In this study, we conducted TGF-β1-based CRISPR/Cas9 gene therapy for RILI.
OBJECTIVE: Mouse lungs were irradiated with a single-dose of 20-Gy gamma rays followed by intravenous administration of Ad-CRISPR-TGF-β1 or Ad- CRISPR-Null.
METHODS: Haematoxylin and eosin staining, as well as Masson staining, were performed to observe lung morphology. Albumin and IgM concentrations in bronchoalveolar lavage fluid were measured by ELISA. Cytokine levels were measured using ELISA and/or real-time PCR with terminal deoxynucleotidyl transferase-mediated nick-end labelling.
RESULTS: Ad-CRISPR-TTGF-β1 improved histopathological and biochemical markers of lung injury, reduced secretion and expression of inflammatory cytokines, and inhibited progression of fibrosis. Importantly, the SK1/S1P axis, which is known to play a key role via S1P1 in TGF-β1-dependent S1PR pattern remodelling, is responsible for promoting fibrosis.
CONCLUSION: Our results indicate novel insights for RILI therapy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  CRISPR/Cas9; fibrosis; gene therapy; inflammation; lung

Mesh:

Substances:

Year:  2022        PMID: 33380298     DOI: 10.2174/1566523220666201230100523

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.676


  2 in total

Review 1.  Targeting angiogenesis in myocardial infarction: Novel therapeutics (Review).

Authors:  Jiejie Li; Yuanyuan Zhao; Wei Zhu
Journal:  Exp Ther Med       Date:  2021-11-22       Impact factor: 2.447

2.  MicroRNA expression changes in Parkinson's disease (PD) patients' leukocytes prior to and following deep brain stimulation (DBS).

Authors:  Soreq Lilach; Bergman Hagai; Israel Zvi; Soreq Hermona; Mohamed Wael
Journal:  Am J Neurodegener Dis       Date:  2021-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.